Interesting development- USFDA has accepted KarXT for review under New Drug Application (NDA) submission for Karuna’s investigational treatment in schizophrenia.
| Subscribe To Our Free Newsletter |
Neuland Laboratories Limited – Transformation towards niche APIs?
